Trials / Completed
CompletedNCT01977157
Alcohol Detection Via Bioimpedance Mesurements
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (actual)
- Sponsor
- RWTH Aachen University · Academic / Other
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Examination if the bioimpendanz measurement can be used for the determination of the alcohol content in human blood. Furthermore the blood alcohol content (BAC) will be estimated by an official breathalyzer and one blood test.
Detailed description
In this clinical trail it will be analyzed, if it is possible to assess the blood alcohol content (BAC) with the bioimpedance devices (SFB7, ImpediMed; Nicomo). This technology is non-invasive an can be measured by using conductive electrodes, capacitive electrodes or inductive measurement systems. The BIS-values will be compared with an official breathanalyzer (Alcotest 7110 Evidential MK III, Dräger, Lübeck, Germany). Furthermore one blood sample will be taken and analyzed with the ADH method as the current gold standard at the end of the trail.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | bioimpedance mesurements | Bioimpedance measurements were conducted with a BIS device (SFB7, ImpediMed, Pinkeba, Australia) covering a frequency range between 5 kHz and 1 MHz and an ICG device (Niccomo, medis, Ilmenau, Germany) |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2012-10-01
- Completion
- 2013-10-01
- First posted
- 2013-11-06
- Last updated
- 2013-11-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01977157. Inclusion in this directory is not an endorsement.